Avadel Pharmaceuticals plc’s recently made public that its Chief Financial Officer MCHUGH THOMAS S acquired Company’s shares for reported $24019.0 on Dec 13 ’24. In the deal valued at $10.44 per share,2,300 shares were bought. As a result of this transaction, MCHUGH THOMAS S now holds 87,800 shares worth roughly $0.91 million.
Then, MCHUGH THOMAS S bought 5,000 shares, generating $52,432 in total proceeds. Upon buying the shares at $10.49, the Chief Financial Officer now owns 85,500 shares.
Before that, Divis Gregory J bought 9,598 shares. Avadel Pharmaceuticals plc shares valued at $95,759 were divested by the Chief Executive Officer at a price of $9.98 per share. As a result of the transaction, Divis Gregory J now holds 9,598 shares, worth roughly $98955.38.
Rodman & Renshaw initiated its Avadel Pharmaceuticals plc [AVDL] rating to a Buy in a research note published on June 12, 2024; the price target was $27. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who remained covering the stock and in early March has reiterated a ‘”an Outperform”‘ rating for it. Needham also remained covering AVDL and reiterated its “Buy” recommendation on March 05, 2024. H.C. Wainwright maintained its rating on March 05, 2024. It rated AVDL as “a Buy”.
Price Performance Review of AVDL
On Friday, Avadel Pharmaceuticals plc [NASDAQ:AVDL] saw its stock jump 1.98% to $10.31. Over the last five days, the stock has lost -0.77%. Avadel Pharmaceuticals plc shares have fallen nearly -26.98% since the year began. Nevertheless, the stocks have fallen -23.97% over the past one year. While a 52-week high of $19.09 was reached on 05/03/24, a 52-week low of $9.41 was recorded on 12/03/24. SMA at 50 days reached $12.23, while 200 days put it at $14.81.
Levels Of Support And Resistance For AVDL Stock
The 24-hour chart illustrates a support level at 10.02, which if violated will result in even more drops to 9.72. On the upside, there is a resistance level at 10.57. A further resistance level may holdings at 10.82. The Relative Strength Index (RSI) on the 14-day chart is 41.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 55.66%. Stochastics %K at 38.78% indicates the stock is a holding.
How much short interest is there in Avadel Pharmaceuticals plc?
A steep rise in short interest was recorded in Avadel Pharmaceuticals plc stocks on 2024-11-29, growing by 0.34 million shares to a total of 9.79 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 9.45 million shares. There was a rise of 3.46%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 06, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $21 price target.
